Recent topics on basic research for idiopathic thrombocytopenic purpura

M. Kuwana, Yutaka Kawakami, Y. Ikeda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by increased platelet clearance caused by anti-platelet autoantibodies, which bind to circulating platelets resulting in destruction. by the reticuloendothelial system. We have recently developed enzyme-linked immunospot assay to detect circulating B cells secreting anti-platelet antibody. An increase in anti-platelet antibody-producing B cells in peripheral blood was specifically detected in ITP patients, but in none of thrombocytopenic patients without ITP or healthy donors. While earlier studies reported the presence of platelet-reactive T cells in ITP patients, we have recently found that GPIIb-IIIa is one of major target antigens recognized by platelet-reactive CD4+ T cells. Since GPIIb-IIIa-reactive CD4+ T cells had helper activity promoting production of anti-platelet antibody, these autoreactive T cells are involved in production of pathogenic anti-platelet autoantibody in ITP patients. Suppression of GPIIb-IIIa-reactive CD4+ T cells may be of therapeutic use in treating refractory patients.

Original languageEnglish
Pages (from-to)992-995
Number of pages4
JournalRinsho byori. The Japanese journal of clinical pathology
Volume49
Issue number10
Publication statusPublished - 2001 Oct

Fingerprint

Idiopathic Thrombocytopenic Purpura
Blood Platelets
Research
T-Lymphocytes
Anti-Idiotypic Antibodies
Autoantibodies
B-Lymphocytes
Enzyme-Linked Immunospot Assay
Antibody-Producing Cells
Mononuclear Phagocyte System
Therapeutic Uses
Helper-Inducer T-Lymphocytes
Autoimmune Diseases
Tissue Donors
Antigens

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Recent topics on basic research for idiopathic thrombocytopenic purpura. / Kuwana, M.; Kawakami, Yutaka; Ikeda, Y.

In: Rinsho byori. The Japanese journal of clinical pathology, Vol. 49, No. 10, 10.2001, p. 992-995.

Research output: Contribution to journalArticle

Kuwana, M. ; Kawakami, Yutaka ; Ikeda, Y. / Recent topics on basic research for idiopathic thrombocytopenic purpura. In: Rinsho byori. The Japanese journal of clinical pathology. 2001 ; Vol. 49, No. 10. pp. 992-995.
@article{ce277c33b00540829e492e78a0db9cb0,
title = "Recent topics on basic research for idiopathic thrombocytopenic purpura",
abstract = "Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by increased platelet clearance caused by anti-platelet autoantibodies, which bind to circulating platelets resulting in destruction. by the reticuloendothelial system. We have recently developed enzyme-linked immunospot assay to detect circulating B cells secreting anti-platelet antibody. An increase in anti-platelet antibody-producing B cells in peripheral blood was specifically detected in ITP patients, but in none of thrombocytopenic patients without ITP or healthy donors. While earlier studies reported the presence of platelet-reactive T cells in ITP patients, we have recently found that GPIIb-IIIa is one of major target antigens recognized by platelet-reactive CD4+ T cells. Since GPIIb-IIIa-reactive CD4+ T cells had helper activity promoting production of anti-platelet antibody, these autoreactive T cells are involved in production of pathogenic anti-platelet autoantibody in ITP patients. Suppression of GPIIb-IIIa-reactive CD4+ T cells may be of therapeutic use in treating refractory patients.",
author = "M. Kuwana and Yutaka Kawakami and Y. Ikeda",
year = "2001",
month = "10",
language = "English",
volume = "49",
pages = "992--995",
journal = "Rinsho byori. The Japanese journal of clinical pathology",
issn = "0047-1860",
publisher = "Nihon Rinsho Byori Gakkai",
number = "10",

}

TY - JOUR

T1 - Recent topics on basic research for idiopathic thrombocytopenic purpura

AU - Kuwana, M.

AU - Kawakami, Yutaka

AU - Ikeda, Y.

PY - 2001/10

Y1 - 2001/10

N2 - Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by increased platelet clearance caused by anti-platelet autoantibodies, which bind to circulating platelets resulting in destruction. by the reticuloendothelial system. We have recently developed enzyme-linked immunospot assay to detect circulating B cells secreting anti-platelet antibody. An increase in anti-platelet antibody-producing B cells in peripheral blood was specifically detected in ITP patients, but in none of thrombocytopenic patients without ITP or healthy donors. While earlier studies reported the presence of platelet-reactive T cells in ITP patients, we have recently found that GPIIb-IIIa is one of major target antigens recognized by platelet-reactive CD4+ T cells. Since GPIIb-IIIa-reactive CD4+ T cells had helper activity promoting production of anti-platelet antibody, these autoreactive T cells are involved in production of pathogenic anti-platelet autoantibody in ITP patients. Suppression of GPIIb-IIIa-reactive CD4+ T cells may be of therapeutic use in treating refractory patients.

AB - Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by increased platelet clearance caused by anti-platelet autoantibodies, which bind to circulating platelets resulting in destruction. by the reticuloendothelial system. We have recently developed enzyme-linked immunospot assay to detect circulating B cells secreting anti-platelet antibody. An increase in anti-platelet antibody-producing B cells in peripheral blood was specifically detected in ITP patients, but in none of thrombocytopenic patients without ITP or healthy donors. While earlier studies reported the presence of platelet-reactive T cells in ITP patients, we have recently found that GPIIb-IIIa is one of major target antigens recognized by platelet-reactive CD4+ T cells. Since GPIIb-IIIa-reactive CD4+ T cells had helper activity promoting production of anti-platelet antibody, these autoreactive T cells are involved in production of pathogenic anti-platelet autoantibody in ITP patients. Suppression of GPIIb-IIIa-reactive CD4+ T cells may be of therapeutic use in treating refractory patients.

UR - http://www.scopus.com/inward/record.url?scp=0035488430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035488430&partnerID=8YFLogxK

M3 - Article

C2 - 11769478

AN - SCOPUS:0035488430

VL - 49

SP - 992

EP - 995

JO - Rinsho byori. The Japanese journal of clinical pathology

JF - Rinsho byori. The Japanese journal of clinical pathology

SN - 0047-1860

IS - 10

ER -